Cellular quiescence: How TGFβ protects cancer cells from chemotherapy
Using a functional proliferation reporter we identified quiescent tumor propagating cancer cells (TPCs) in intact squamous cell carcinomas, and found that TGFβ signaling controls their reversible entry into a growth arrested state, which protects TPCs from chemotherapy. TPCs with compromised TGFβ/Sm...
Main Authors: | Jessie A Brown, Markus Schober |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-03-01
|
Series: | Molecular & Cellular Oncology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/23723556.2017.1413495 |
Similar Items
-
A novel GPI-anchored dominant-negative TGF-β receptor II renders T cells unresponsive to TGF-β signaling
by: Sven H. Petersen, et al.
Published: (2023-12-01) -
Crack the state of silence: Tune the depth of cellular quiescence for cancer therapy
by: Kotaro Fujimaki, et al.
Published: (2018-01-01) -
Yeast quiescence exit swiftness is influenced by cell volume and chronological age
by: Damien Laporte, et al.
Published: (2017-12-01) -
Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of TGFβ
by: Markus Germann, et al.
Published: (2019-12-01) -
Specifically blocking αvβ8-mediated TGF-β signaling to reverse immunosuppression by modulating macrophage polarization
by: Cuicui Guo, et al.
Published: (2025-01-01)